General Announcement::Tender Offer & Consent Solicitation 2 per Resettable Onward Starting Securities due2022

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
12-Apr-2021 18:57:46
Status
New
Announcement Sub Title
Tender Offer & Consent Solicitation 2 per Resettable Onward Starting Securities due2022
Announcement Reference
SG210412OTHR3O1M
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary and Compliance Officer
Effective Date and Time of the event
12/04/2021 00:00:00
Description (Please provide a detailed description of the event in the box below)
The Issuer wishes to announce today the results of the Proposal and the Meeting pursuant to the tender offer and solicitation memorandum dated 19 March 2021

Attachments

SGX Announcement 12042021.pdf
Total size =240K